Screener
Xencor XNCR Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $51.22M+17.5% | $4.52M-86.2% | $28.24M-46.5% | $21M+18.0% | $43.61M+82.4% | ||
| $71.91M+16.6% | $64.67M+10.4% | $64.82M+27.0% | $54.37M-6.6% | $61.67M+0.2% | ||
| $16.38M+8.4% | $17.71M+2.1% | $17.04M+14.3% | $14.15M-4.2% | $15.12M-14.8% | ||
| $88.29M+15.0% | $82.38M+8.5% | $81.87M+24.1% | $68.52M-6.1% | $76.78M-3.1% | ||
| -$37.07M-11.7% | -$77.86M-80.3% | -$53.63M-307% | -$47.52M+13.9% | -$33.17M+40.1% | ||
| -72.4%+3.7pp | -1,724.1%-1,592pp | -189.9%-165pp | -226.3%+83.9pp | -76.1%+156pp | ||
| $7.35M-10.8% | $4.7M-45.8% | $7.35M-15.1% | $7.67M-15.1% | $8.24M-11.2% | ||
| $15.15M+622% | -$50.77M-899% | $49.36M+257% | $41.49M+435% | $2.1M+116% | ||
| -$21.92M+29.5% | -$128.64M-167% | -$4.27M+90.4% | -$6.03M+87.3% | -$31.08M+54.8% | ||
| -$190K+24.0% | $280K-23.7% | $2.39M+47.6% | $0— | -$250K— | ||
| -$21.73M+29.5% | -$128.92M-166% | -$6.65M+85.4% | -$6.03M+87.0% | -$30.83M+54.2% | ||
| -42.4%+28.3pp | -2,854.7%-2,707pp | -23.6%+62.7pp | -28.7%+231pp | -70.7%+211pp | ||
| -$0.29+29.3% | -$1.71-159% | -$0.09+84.5% | -$0.08+88.9% | -$0.41+62.4% | ||
| -$34.63M-13.5% | -$75.3M-86.0% | -$51.05M-401% | -$44.93M+13.8% | -$30.52M+41.7% | ||
| -67.6%+2.4pp | -1,667.3%-1,544pp | -180.8%-162pp | -214%+79.0pp | -70%+149pp | ||
| -$37.07M-11.7% | -$77.86M-80.3% | -$53.63M-307% | -$47.52M+13.9% | -$33.17M+40.1% |
FAQ
- What is Xencor's revenue?
- Xencor (XNCR) generated $105.0M in revenue over the trailing twelve months, down 28.6% year over year.
- Is Xencor profitable?
- Xencor is not currently profitable: it reported a net loss of $163.3M over the trailing twelve months, a -155.6% net margin.
- What is Xencor's earnings per share?
- Xencor's diluted EPS over the trailing twelve months is $-2.17.
- Where does Xencor's income statement data come from?
- Every line is extracted from Xencor's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
